Allergy & Immunology
IVIG
agammaglobulinemia
Condition
Learn about agammaglobulinemia and monitored outpatient immunoglobulin (IVIG) replacement therapy at Infuse Care.
Specialty
Therapies we administer
Agammaglobulinemia is a rare, usually inherited immune disorder in which the body makes very few B cells and little or no antibodies. The most common form, X-linked agammaglobulinemia, mainly affects boys and often becomes noticeable in early childhood, once the antibodies passed on from the mother fade. Without antibodies, bacterial and some viral infections can be frequent and serious.
Contact a provider about frequent or severe infections, infections that needed IV antibiotics, or a family history of agammaglobulinemia. If you are already on treatment, report a fever or new infection promptly.
The main treatment is lifelong immunoglobulin (antibody) replacement, prescribed by an immunologist. Regular doses supply antibodies the body cannot make and may help reduce how often infections happen and how severe they are. Immunoglobulin can be given by IV infusion (IVIG) every few weeks or as more frequent injections under the skin (SCIG).
Headache, chills, tiredness and flushing can occur during or after an infusion. Rare but serious risks include blood clots and kidney problems, so your provider reviews your health history and our nurses adjust the infusion rate and encourage hydration. Live vaccines are generally avoided.
Your prescribing provider decides which treatment is right for you. Infuse Care administers prescribed therapies after a referral, a clinical review and any required insurance authorization, and we keep your provider's office updated on your care.
More in this specialty
For patients
Call our team and we'll coordinate with your doctor and insurance.